Heron Therapeutics Announces U.S. FDA Approval of SUSTOL® (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Go back to Heron Therapeutics Announces U.S. FDA Approval of SUSTOL® (granisetron) Extended-Release Injection for the Prevention of Chemotherapy-Induced Nausea and Vomiting| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.42 -0.01 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $31.32 | |||
| Open | $0.42 | 52 Week Low | $13.95 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.41 | EPS | $-3.29 | |||
| Volume | 2,893,205 | |||||
